Inducible Resistance to Amikacin in

Mycobacterium abscessus amikacin inducible intrinsic resistance

Journal

Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216

Informations de publication

Date de publication:
2022
Historique:
received: 20 01 2022
accepted: 01 04 2022
entrez: 5 5 2022
pubmed: 6 5 2022
medline: 6 5 2022
Statut: epublish

Résumé

We aimed to determine the prevalence of amikacin (AMK) resistance of clinical

Identifiants

DOI: 10.2147/IDR.S357887 PMID: 35510159 PMC: PMC9059872
pubmed: 35510159
doi: 10.2147/IDR.S357887
pii: 357887
pmc: PMC9059872
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2287-2291

Informations de copyright

© 2022 Zhang et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Antimicrob Agents Chemother. 2012 Apr;56(4):2074-83
pubmed: 22232275
J Antimicrob Chemother. 2012 Apr;67(4):810-8
pubmed: 22290346
Infect Drug Resist. 2020 Jun 26;13:2001-2010
pubmed: 32617011
Clin Chest Med. 2015 Mar;36(1):13-34
pubmed: 25676516
Antimicrob Agents Chemother. 2009 Apr;53(4):1367-76
pubmed: 19171799
Sci Rep. 2021 Mar 17;11(1):6108
pubmed: 33731862
Nat Commun. 2021 Aug 26;12(1):5145
pubmed: 34446725
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28874378
Drug Resist Updat. 2010 Dec;13(6):151-71
pubmed: 20833577
Antimicrob Agents Chemother. 2007 Dec;51(12):4401-9
pubmed: 17875999
J Infect Dis. 1998 Jun;177(6):1573-81
pubmed: 9607835
Nat Rev Microbiol. 2020 Jul;18(7):392-407
pubmed: 32086501
J Clin Microbiol. 2019 Jul 26;57(8):
pubmed: 31167842
Am J Respir Crit Care Med. 2009 Nov 1;180(9):896-902
pubmed: 19661243
ERJ Open Res. 2019 May 10;5(2):
pubmed: 31149626
J Antimicrob Chemother. 2016 Aug;71(8):2208-12
pubmed: 27147307
Am J Respir Crit Care Med. 2011 Feb 1;183(3):405-10
pubmed: 20833823
J Mol Diagn. 2021 Nov;23(11):1460-1467
pubmed: 34454109
Antimicrob Agents Chemother. 2015 Sep;59(9):5851-3
pubmed: 26169410
J Antimicrob Chemother. 2011 Aug;66(8):1719-24
pubmed: 21652621
Clin Infect Dis. 2020 Aug 14;71(4):905-913
pubmed: 32797222
Molecules. 2017 Dec 19;22(12):
pubmed: 29257114
Clin Infect Dis. 2007 Jul 1;45(1):88-94
pubmed: 17554708

Auteurs

Zhijian Zhang (Z)

Department of Respiratory and Critical Care Medicine, the Second Medical Center of Chinese PLA General Hospital, Beijing, 100036, People's Republic of China.

Wei Wang (W)

Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing, 101149, People's Republic of China.

Yufeng Wang (Y)

Innovation Alliance on Tuberculosis Diagnosis and Treatment, Beijing, 101149, People's Republic of China.

Zhongtan Xue (Z)

Innovation Alliance on Tuberculosis Diagnosis and Treatment, Beijing, 101149, People's Republic of China.

Shanshan Li (S)

Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing, 101149, People's Republic of China.
ORCID: 0000-0003-4475-4536

Yu Pang (Y)

Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing, 101149, People's Republic of China.
ORCID: 0000-0001-6803-9807

Classifications MeSH